Is pharmacological, H2S-induced 'suspended animation' feasible in the ICU?

Critical Care

Volumn 18, Issue 2, 2014, Pages

  Asfar, Pierre ^a   Calzia, Enrico ^b   Radermacher, Peter ^b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CARBON 13; CARBON DIOXIDE; GYY 4137; HYDROGEN SULFIDE; ISOFLURANE; NORADRENALIN; OXYGEN; SODIUM SULFIDE; UNCLASSIFIED DRUG;

ANESTHESIA; ANTIINFLAMMATORY ACTIVITY; BODY TEMPERATURE; BRADYPNEA; COLD ACCLIMATIZATION; COOLING; ENERGY EXPENDITURE; ENERGY METABOLISM; HEMODYNAMICS; HUMAN; HYPOTHERMIA; HYPOXIA; INDUCED HYPOTHERMIA; INTENSIVE CARE UNIT; INTRAVENOUS ANESTHESIA; MEMBRANE OXYGENATOR; METABOLIC ACIDOSIS; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; REVIEW; RODENT MODEL; SHOCK; SUSPENDED ANIMATION; ANIMAL; DEEP HYPOTHERMIC CIRCULATORY ARREST; DRUG EFFECTS; FEASIBILITY STUDY; OXYGEN CONSUMPTION; PHYSIOLOGY; PROCEDURES; TRENDS;

ANIMALS; BODY TEMPERATURE; CIRCULATORY ARREST, DEEP HYPOTHERMIA INDUCED; FEASIBILITY STUDIES; HUMANS; HYDROGEN SULFIDE; INTENSIVE CARE UNITS; OXYGEN CONSUMPTION;

EID: 84897449676     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13782     Document Type: Review

References (51)

1. Suspended animation. Accessed Nov 2013., http://en.wikipedia.org/wiki/Suspended_animation
2. Singer M, De Santis V, Vitale D, Jeffcoate W. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004, 364:545-548. 10.1016/S0140-6736(04)16815-3, 15302200.
3. Blackstone E, Morrison M, Roth MB. H2S induces a suspended animation-like state in mice. Science 2005, 308:518. 10.1126/science.1108581, 15845845.
4. Volpato GP, Searles R, Yu B, Scherrer-Crosbie M, Bloch KD, Ichinose F, Zapol WM. Inhaled hydrogen sulfide: a rapidly reversible inhibitor of cardiac and metabolic function in the mouse. Anesthesiology 2008, 108:659-668. 10.1097/ALN.0b013e318167af0d, 2838418, 18362598.
5. Blackstone E, Roth MB. Suspended animation-like state protects mice from lethal hypoxia. Shock 2007, 27:370-372. 10.1097/SHK.0b013e31802e27a0, 17414418.
6. Morrison ML, Blackwood JE, Lockett SL, Iwata A, Winn RK, Roth MB. Surviving blood loss using hydrogen sulfide. JTrauma 2008, 65:183-188.
7. Bos EM, Leuvenink HG, Snijder PM, Kloosterhuis NJ, Hillebarnds JL, Leemans JC, Glorquin S, van Goor H. Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury. J Am Soc Nephrol 2009, 20:1901-1905. 10.1681/ASN.2008121269, 2736772, 19628669.
8. Faller S, Ryter SW, Choi AM, Loop T, Schmidt R, Hoetzel A. Inhaled hydrogen sulfide protects against ventilator-induced lung injury. Anesthesiology 2010, 113:104-115. 10.1097/ALN.0b013e3181de7107, 20574227.
9. Bos EM, Snijder PM, Jekel H, Weij M, Leemans JC, van Dijk MC, Hillebarnds JL, Lisman T, van Goor H, Leuvenink HG. Beneficial effects of gaseous hydrogen sulfide in hepatic ischemia/reperfusion injury. Transpl Int 2012, 25:897-908. 10.1111/j.1432-2277.2012.01514.x, 22716165.
10. Seitz DH, Froba JS, Niesler U, Palmer A, Veltkamp HA, Braumüller ST, Wagner F, Wagner K, Bäder S, Wachter U, Calzia E, Radermacher P, Huber-Lang MS, Zhou S, Gebhard F, Knoferl MW. Inhaled hydrogen sulfide induces suspended animation, but does not alter the inflammatory response after blunt chest trauma. Shock 2012, 37:197-204. 10.1097/SHK.0b013e31823f19a0, 22089191.
11. Tokuda K, Kida K, Marutani E, Crimi E, Bougaki M, Khatri A, Kimura H, Ichinose F. Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice. Antioxid Redox Signal 2012, 17:11-21. 10.1089/ars.2011.4363, 3342565, 22221071.
12. Snijder PM, de Boer RA, Bos EM, van den Born JC, Ruifrok WP, Vreeswijk- Baudoin I, can Dijk MC, Hillebrands JL, Leuveninink HG, van Goor H. Gaseous hydrogen sulfide protects against myocardial ischemia-reperfusion injury in mice partially independent from hypometabolism. PLoS One 2013, 8:e63291. 10.1371/journal.pone.0063291, 3651205, 23675473.
13. Aslami H, Heinen A, Roelofs JJTH, Zuurbier CJ, Schultz MJ, Juffermans NP. Suspended animation inducer hydrogen sulfide is protective in an in vivo model of ventilator-induced lung injury. Intensive Care Med 2010, 36:1946-1952. 10.1007/s00134-010-2022-2, 2952106, 20721529.
14. Aslami H, Pulskens WP, Kuipers MT, Bos AP, van Küllenburg AB, Wander RJ, Roelofsen J, Roelofs JJ, Kerindongo RP, Beurskens CJ, Schultz MJ, Kulik W, Weber NC, Juffermans NP. Hydrogen sulfide donor NaHS reduces organ injury in a rat model of pneumococcal pneumosepsisassociated with improved bio-energetic status. PLoS One 2013, 8:e63497. 10.1371/journal.pone.0063497, 3662774, 23717435.
15. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scala R, Kiss L, Szabo C, Kimura H, Chow CW, Lefer DJ. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 2007, 104:15560-15565. 10.1073/pnas.0705891104, 2000503, 17878306.
16. Baumgart K, Wagner F, Groger M, Weber S, Barth E, Vogt JA, Wachter U, Huber-Lang M, Knoferl MW, Albuszies G, Georgieff M, Asfar P Szabó C, Calzia E, Radermacher P, Simkova V. Cardiac and metabolic effects of hypothermia and inhaled hydrogen sulfide in anesthetized and ventilated mice. Crit Care Med 2010, 38:588-595. 10.1097/CCM.0b013e3181b9ed2e, 20095069.
17. Li RQ, McKinstry AR, Moore JT, Caltagarone BM, Echkenhoff MF, Eckenhoff RG, Kelz MB. Is hydrogen sulfide-induced suspended animation general anesthesia?. J Pharmacol Exp Ther 2012, 341:735-742. 10.1124/jpet.111.187237, 3362879, 22414854.
18. Haouzi P, Bell HJ, Notet V, Bihain B. Comparison of the metabolic and ventilatory response to hypoxia and H2S in unsedated mice and rats. Respir Physiol Neurobiol 2009, 2:316-322.
19. Li J, Zhang G, Cai S, Redington AN. Effect of inhaled hydrogen sulfide on metabolic responses in anesthetizedparalyzedand mechanically ventilated piglets. Pediatr Crit Care Med 2008, 9:110-112. 10.1097/01.PCC.0000298639.08519.0C, 18477923.
20. Haouzi P, Notet V, Chenuel B, Chalon B, Sponne I, Ogier V, Bihain B. induced hypometabolism in mice is missing in sedated sheep. Respir Physiol Neurobiol 2008, 160:109-115. 10.1016/j.resp.2007.09.001, 17980679.
21. Derwall M, Westerkamp M, Lower C, Deike-Glindemann J, Schnorrenberger NK, Coburn M, Nolte KW, Gaisa N, Weis J, Siepmann K, Häusler M, Rossaint R, Fries M. Hydrogen sulfide does not increase resuscitability in a porcine model of prolonged cardiac arrest. Shock 2010, 34:190-195. 10.1097/SHK.0b013e3181d0ee3d, 20090564.
22. Drabek T, Kochanek PM, Stezoski J, Wu X, Bayir H, Morhard RC, Stezoski RC, Tisherman SA. Intravenous hydrogen sulfide does not induce hypothermia or improve survival from hemorrhagic shock in pigs. Shock 2011, 35:67-73. 10.1097/SHK.0b013e3181e86f49, 20523266.
23. Derwall M, Francis RC, Kida K, Bougaki M, Crimi E, Adrie C, Zapol WM, Ichinose F. Administration of hydrogen sulfide via extracorporeal membrane lung ventilation in sheep with partial cardiopulmonary bypass perfusion: a proof of concept study on metabolic and vasomotor effects. Crit Care 2011, 15:R51. 10.1186/cc10016, 3221981, 21299857.
24. Simon F, Giudici R, Duy CN, Schelzig H, Oter S, Groger M, Wachter U, Vogt J, Speit G, Szabó C, Radermacher P, Calzia E. Hemodynamic and metabolic effects of hydrogen sulfide during porcine ischemia/reperfusion injury. Shock 30:359-364.
25. Francis RC, Vaporidi K, Bloch KD, Ichinose F, Zapol WM. Protective and detrimental effects of sodium sulfide and hydrogen sulfide in murine ventilator-induced lung injury. Anesthesiology 2011, 115:1012-1021. 10.1097/ALN.0b013e31823306cf, 3752661, 21912243.
26. Bhambani Y, Burnham R, Snydmiller G, MacLean IJ. Effects of 10-ppm hydrogen sulfide inhalation in exercising men and women. Cardiovascular, metabolic, and biochemical responses. J Occup Environ Med 1997, 39:122-129. 10.1097/00043764-199702000-00009, 9048318.
27. Tisherman SA, Drabek T. Hydrogen sulfide: metabolic mediator or toxic gas?. Pediatr Crit Care Med 2008, 9:129-130. 10.1097/01.PCC.0000299823.48057.E4, 18185132.
28. Haouzi P. Murine models in critical care research. Crit Care Med 2011, 39:2290-2293. 10.1097/CCM.0b013e3182227550, 21666454.
29. Simon F, Scheuerle A, Groger M, Stahl B, Wachter U, Vogt J, Speit G, Hauser B, Moller P, Calzi E, Szabó C, Schelzig H, Georgieff M, Radermacher P, Wagner F. Effects of intravenous sulfide during porcine aortic occlusion-induced kidney ischemia/reperfusion injury. Shock 2011, 35:156-163. 10.1097/SHK.0b013e3181f0dc91, 20661185.
30. Bracht H, Scheuerle A, Groger M, Hauser B, Matallo J, McCook O, Seifritz A, Wachter U, Vogt JA, Asfar P, Matejovic M, Moller P, Calzia E, Szabó C, Stahl W, Hoppe K, Stahl B, Lampl L, Georgieff M, Wagner F, Radermacher P, Simon F. Effects of intravenous sulfide during resuscitated porcine hemorrhagic shock. Crit Care Med 2012, 40:2157-2167. 10.1097/CCM.0b013e31824e6b30, 22713217.
31. Mortola JP. Hypoxic hypometabolism in mammals. News Physiol Scie 1993, 8:79-82.
32. van Marken Lichtenbelt WD, Schrauwen P. Implications of nonshivering thermogenesis for energy balance regulation in humans. Am J Physiol Regul Integr Comp Physio! 2011, 301:R285-R296.
33. Hosgood SA, Nicholson ML. Hydrogen sulphide ameliorates ischaemia- reperfusion injury in an experimental model of non-heart-beating donor kidney transplantation. BrJSurg 2010, 97:202-209.
34. Wagner F, Wagner K, Weber S, Stahl B, Knoferl MW, Huber-Lang M, Seitz DH, Asfar P, Calzia E, Senftleben U, Gebhard F, Georgieff M, Radermacher P, Hysa V. Inflammatory effects of hypothermia and inhaled during resuscitatedhyperdynamic murine septic shock. Shock 2011, 2(35):396-402.
35. Wagner F, Scheuerle A, Weber S, Stahl B, McCook O, Knoferl MW, Huber-Lang M, Seitz DH, Thomas J, Asfar P, Szabó C, Moller P, Gebhard F, Goergieff M, Calzia E, Radermacher P, Wagner K. Cardiopulmonaryhistologicand inflammatory effects of intravenous ^S after blunt chest trauma- induced lung contusion in mice. J Trauma 2011, 71:1659-1667. 10.1097/TA.0b013e318228842e, 21857260.
36. Esechie A, Enkhbaatar P, Traber DL, Jonkam C, Lange M, Hamahata A, Djukom C, Whorton EB, Hawkins HK, Traber LD, Szabo C. Beneficial effect of a hydrogen sulphide donor (sodium sulphide) in an ovine model of burn- and smoke-induced acute lung injury. Br J Pharmacol 2009, 158:1442-1453. 10.1111/j.1476-5381.2009.00411.x, 2795211, 19845680.
37. Minamishima S, Bougaki M, Sips PY, Yu JD, Minashima YA, Elrod JW, Lefer DJ, Bloch KD, Ichinose F. Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. Circulation 2009, 120:888-896. 10.1161/CIRCULATIONAHA.108.833491, 2768477, 19704099.
38. Sodha NR, Clements RT, Feng J, Liu Y, Bianchi C, Horvath EM, Szabo C, Sellke FW. The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. EurJCardiothoracSurg 2008, 33:906-913.
39. Osipov RM, Robich MP, Feng J, Liu Y, Clements RT, Glazer HP, Sodha NR, Szabo C, Bianchi C, Sellke FW. Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection. J Cardiovasc Pharmacol 2009, 54:287-297. 10.1097/FJC.0b013e3181b2b72b, 19620880.
40. Sodha NR, Clements RT, Feng J, Liu Y, Bianchi C, Horvath EM, Szabo C, Stahl GL, Sellke FW. Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury. J Thorac Cardiovasc Surg 2009, 138:977-984. 10.1016/j.jtcvs.2008.08.074, 2758694, 19660398.
41. Osipov RM, Robich MP, Feng J, Chan V, Clements RT, Deyo RJ, Szabo C, Sellke FW. Effect of hydrogen sulfide on myocardial protection in the setting of cardioplegia and cardiopulmonary bypass. interact Cardiovasc Thorac Surg 2010, 10:506-512. 10.1510/icvts.2009.219535, 20051450.
42. Hunter JP, Hosgood SA, Patel M, Rose R, Read K, Nicholson ML. Effects of hydrogen sulphide in an experimental model of renal ischaemia- reperfusion injury. Br J Surg 2012, 99:1665-1671. 10.1002/bjs.8956, 23132416.
43. Chen Z, Chen H, Rhee P, Koustova E, Ayuste EC, Honma K, Nadel A, Alam HB. Induction of profound hypothermia modulates the immune/ inflammatory response in a swine model of lethal hemorrhage. Resuscitation 2005, 66:209-216. 10.1016/j.resuscitation.2005.01.021, 16053944.
44. Cooper CE, Brown GC. The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance. J Bioenerg Biomembr 2008, 40:533-539. 10.1007/s10863-008-9166-6, 18839291.
45. Groger M, Matallo J, McCook O, Wagner F, Wachter U, Bastían O, Gierer S, Reich V, Stahl B, Huber-Lang M, Szabó C, Radermacher P, Calzia E, Wagner K. Temperature and cell-type dependency of sulfide effects on mitochondrial respiration. Shock 2012, 38:367-374. 10.1097/SHK.0b013e3182651fe6, 22777116.
46. Leverve X, Batandier C, Fontaine E. Choosing the right substrate. Novartis FoundSymp 2007, 280:108-121.
47. Drabek T. Hydrogen sulfide-curiouser and curiouser!. Crit Care Med 2012, 40:2255-2256. 10.1097/CCM.0b013e318251507d, 22710225.
48. Whiteman M, Li L, Rose P, Tan C, Parkinson DB, Moore PK. The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages. Antioxid Redox Signal 2010, 12:1147-1154. 10.1089/ars.2009.2899, 2875982, 19769459.
49. Roth MB, Nystul T. Buying time in suspended animation. SciAm 2005, 292:48-55.
50. Leslie M. Nothing rotten about hydrogen sulfide's medical promise. Science 2008, 320:1155-1157. 10.1126/science.320.5880.1155, 18511669.
51. Aslami H, Schultz MJ, Juffermans NP. Hydrogen sulfide: a hot molecule. Anesthesiology 2011, 115:921-922. 10.1097/ALN.0b013e318233058a, 21926906.